Investigation of Dientamoeba fragilis and Blastocystis in patients from Turkey with ulcerative colitis and irritable bowel syndrome: Any relation with genotypes?


Journal

Acta tropica
ISSN: 1873-6254
Titre abrégé: Acta Trop
Pays: Netherlands
ID NLM: 0370374

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 23 11 2021
revised: 12 03 2022
accepted: 03 04 2022
pubmed: 8 4 2022
medline: 26 5 2022
entrez: 7 4 2022
Statut: ppublish

Résumé

Blastocystis sp. and Dientamoeba fragilis are two most common protists worldwide, whose pathogenic potentials are a matter of debate since their discovery. This study aims to investigate the relationship between the activation of ulcerative colitis (UC) and irritable bowel syndrome (IBS) with these protists. A total of 100 patients (35 IBS, 35 active UC, and 30 remittent UC), diagnosed at Hacettepe University Adult Hospital (Ankara, Turkey), were screened for D. fragilis and Blastocystis sp. with microscopic examination using the methods of wet mount, trichrome staining, conventional PCR, nested PCR, real-time PCR and genotyping. Eight patients (4 IBS, 2 active, and 2 remittent UC patients) were found to be D. fragilis positive. 18S rRNA region of the parasite was amplified in four of the patients, whereas cathepsin L-like cysteine peptidase; clan Sc, family S9, serine peptidase; and clan MH, family M20 metallopeptidase in six different patients. All isolates were Genotype 1. Sequence results showed very limited diversity. A total of nine patients (3 IBS, 5 active UC, 1 remittent UC) were found to be positive for Blastocystis sp., all of which were Subtype 3. One active UC and one IBS patient were found to be positive for both parasites. No statistically significant difference was detected between the patient groups in means of parasite detection. D. fragilis was found to be related to older age (p=0,045). In our study, no significant correlation was identified between D. fragilis and Blastocystis sp., and the activation of UC and IBS. More studies are needed on the host-parasite relationship, including the role of gut microbiota, together with transcriptomic and metabolomic assessments to unveil the pathogenicity of both protists.

Identifiants

pubmed: 35390312
pii: S0001-706X(22)00145-0
doi: 10.1016/j.actatropica.2022.106451
pii:
doi:

Substances chimiques

Peptide Hydrolases EC 3.4.-

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106451

Informations de copyright

Copyright © 2022 Elsevier B.V. All rights reserved.

Auteurs

Tugce Unalan-Altintop (T)

Hacettepe University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey. Electronic address: t.unalan91@gmail.com.

Cavansir Vahabov (C)

Hacettepe University Faculty of Medicine, Department of Gastroenterology, Ankara, Turkey.

Koray Ergunay (K)

Hacettepe University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey.

Ozgur Kurt (O)

Acibadem Mehmet Ali Aydinlar University Faculty of Medicine, Department of Medical Microbiology, Istanbul, Turkey.

Taylan Kav (T)

Hacettepe University Faculty of Medicine, Department of Gastroenterology, Ankara, Turkey.

Yakut Akyon (Y)

Hacettepe University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey.

Sibel Erguven (S)

Hacettepe University Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH